BioRestorative Therapies, Inc. — All Filings
725 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0002027680-24-000004 | Dec 5, 2024 | — |
| SCHEDULE 13G/A | — | 0001700205-24-000004 | Nov 14, 2024 | — |
| 8-K | THIRD QUARTER RESULTS AND ORS PRESENTATION | 0001021771-24-000195 | Nov 13, 2024 | Nov 12, 2024 |
| S-8 | — | 0001021771-24-000194 | Nov 13, 2024 | — |
| 10-Q | — | 0001493152-24-044763 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | ADDITIONAL PRELIMINARY PHASE 2 DATA AND REVIEW OF THIRD QUARTER CONFERENCE CALL | 0001021771-24-000190 | Nov 7, 2024 | Nov 6, 2024 |
| 8-K | RODMAN & RENSHAW AT THE MARKET OFFERING AGREEMENT | 0001021771-24-000188 | Nov 6, 2024 | Nov 1, 2024 |
| 10-K/A | — | 0001493152-24-043839 | Nov 6, 2024 | Dec 31, 2023 |
| 424B5 | PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED FEBRUARY 14, 2023 | 0001021771-24-000186 | Nov 6, 2024 | — |
| 4 | — | 0001021771-24-000184 | Nov 5, 2024 | Oct 28, 2024 |
| 8-K | SHAREHOLDER VOTE | 0001021771-24-000180 | Sep 23, 2024 | Sep 19, 2024 |
| 8-K | SECOND QUARTER RESULTS | 0001021771-24-000166 | Aug 13, 2024 | — |
| 10-Q | — | 0001493152-24-031636 | Aug 13, 2024 | Jun 30, 2024 |
| DEF 14A | ANNUAL MEETING PROXY STATEMENT | 0001021771-24-000160 | Aug 8, 2024 | Sep 19, 2024 |
| 8-K | PRESS RELEASE RE SECOND QUARTER RESULTS AND CONFERENCE CALL | 0001021771-24-000158 | Aug 6, 2024 | — |
| SCHEDULE 13G | — | 0002027680-24-000002 | Jun 21, 2024 | — |
| 10-K/A | — | 0001493152-24-023479 | Jun 11, 2024 | Dec 31, 2023 |
| 10-Q | — | 0001493152-24-023481 | Jun 11, 2024 | Mar 31, 2024 |
| 8-K | RE DELISTING | 0001021771-24-000142 | May 24, 2024 | May 22, 2024 |
| 8-K | RE: RESTATEMENT | 0001021771-24-000140 | May 24, 2024 | May 23, 2024 |
| NT 10-Q | MARCH 31, 2024 | 0001021771-24-000130 | May 16, 2024 | Mar 31, 2024 |
| 424B3 | 2,513,686 SHARES OF COMMON STOCK | 0001021771-24-000111 | Apr 19, 2024 | — |
| EFFECT | — | 9999999995-24-001030 | Apr 18, 2024 | — |
| CORRESP | — | 0001021771-24-000103 | Apr 17, 2024 | — |
| S-1/A | AMENDMENT NO. 1 | 0001021771-24-000099 | Apr 12, 2024 | — |
| UPLOAD | — | 0000000000-24-003948 | Apr 11, 2024 | — |
| 4 | — | 0001021771-24-000091 | Apr 10, 2024 | Apr 8, 2024 |
| S-1 | S-1 | 0001021771-24-000084 | Apr 3, 2024 | — |
| 10-K | — | 0001493152-24-012056 | Apr 1, 2024 | Dec 31, 2023 |
| 4 | — | 0001021771-24-000079 | Mar 20, 2024 | Mar 18, 2024 |
| 4 | — | 0001021771-24-000077 | Mar 20, 2024 | Mar 18, 2024 |
| 8-K | RE PRESENTATION MATERIALS | 0001021771-24-000068 | Mar 12, 2024 | Mar 11, 2024 |
| SC 13D/A | SCHEDULE 13D AMENDMENT 9 | 0001021771-24-000065 | Mar 6, 2024 | — |
| 4 | — | 0001021771-24-000056 | Feb 15, 2024 | Feb 13, 2024 |
| 4 | — | 0001021771-24-000044 | Feb 15, 2024 | Feb 13, 2024 |
| SC 13D/A | SCHEDULE 13D AMENDMENT 2 | 0001021771-24-000058 | Feb 15, 2024 | — |
| 4 | — | 0001021771-24-000046 | Feb 15, 2024 | Feb 13, 2024 |
| 4 | — | 0001021771-24-000048 | Feb 15, 2024 | Feb 13, 2024 |
| 4 | — | 0001021771-24-000050 | Feb 15, 2024 | Feb 13, 2024 |
| SC 13D/A | SCHEDULE 13D/AMENDMENT 2 | 0001021771-24-000060 | Feb 15, 2024 | — |
| 4 | — | 0001021771-24-000054 | Feb 15, 2024 | Feb 13, 2024 |
| 4 | — | 0001021771-24-000052 | Feb 15, 2024 | Feb 13, 2024 |
| SC 13G/A | — | 0001700205-24-000002 | Feb 14, 2024 | — |
| 4 | — | 0001021771-24-000038 | Feb 12, 2024 | Feb 8, 2024 |
| 4 | — | 0001021771-24-000035 | Feb 9, 2024 | Feb 7, 2024 |
| 8-K | FORM 8-K DATED FEBRUARY 6, 2024 | 0001021771-24-000033 | Feb 8, 2024 | Feb 6, 2024 |
| 8-K | RE AUTOLOGOUS STEM CELL THERAPY POSTER | 0001021771-24-000027 | Feb 5, 2024 | — |
| 8-K | PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL | 0001021771-24-000025 | Feb 1, 2024 | — |
| 4 | — | 0001021771-23-000118 | Dec 5, 2023 | Dec 1, 2023 |
| 4 | — | 0001021771-23-000116 | Dec 1, 2023 | Nov 27, 2023 |